Ischemic Hepatitis as the Presenting Manifestation of Cardiac Amyloidosis

An abrupt elevation in aminotransferases without clear etiology may be attributed to hypoxic hepatitis. Underlying cardiac dysfunction, an important clinical clue, is often overlooked as a cause of hypoxic hepatitis, and understanding the interdependence of the heart and liver is crucial in making this diagnosis. Causes of cardiac dysfunction may include any of many different diagnoses; infiltrative heart disease is a rare cause of cardiac dysfunction, with amyloidosis being the most common among this category of pathologies. More advanced imaging techniques have improved the ability to diagnose infiltrative heart disease, thus allowing quicker diagnosis of conditions such as amyloidosis.

[1]  E. Gonçalvesová,et al.  [Liver in heart failure]. , 2014, Vnitrni lekarstvi.

[2]  J. Henrion Hypoxic hepatitis , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[3]  R. Falk,et al.  Current perspectives on cardiac amyloidosis. , 2012, American journal of physiology. Heart and circulatory physiology.

[4]  V. Figueredo,et al.  Infiltrative diseases of the heart. , 2010, Reviews in cardiovascular medicine.

[5]  J. Dery,et al.  Impact of thrombus aspiration on angiographic and clinical outcomes in patients with ST-elevation myocardial infarction. , 2010, Cardiovascular revascularization medicine : including molecular interventions.

[6]  J. Seward,et al.  Infiltrative cardiovascular diseases: cardiomyopathies that look alike. , 2010, Journal of the American College of Cardiology.

[7]  C. Madl,et al.  Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients , 2009, Intensive Care Medicine.

[8]  K. Klingel,et al.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[9]  A. Delannoy,et al.  Hypoxic Hepatitis: Clinical and Hemodynamic Study in 142 Consecutive Cases , 2003, Medicine.

[10]  D. Rockey,et al.  Ischemic hepatitis: clinical presentation and pathogenesis. , 2000, The American journal of medicine.

[11]  R H Hruban,et al.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.

[12]  M. Whitehead,et al.  A prospective study of the causes of notably raised aspartate aminotransferase of liver origin , 1999, Gut.

[13]  Johnson Rd,et al.  Extreme serum elevations of aspartate aminotransferase , 1995 .

[14]  Robert McDougall Kerr,et al.  Extreme serum elevations of aspartate aminotransferase. , 1995, The American journal of gastroenterology.

[15]  N. Gitlin,et al.  Ischemic hepatitis: widening horizons. , 1992, The American journal of gastroenterology.

[16]  M. Kaplan,et al.  Left-sided heart failure presenting as hepatitis. , 1978, Gastroenterology.

[17]  Mallory Fb Necroses of the Liver. , 1901 .

[18]  F. B. Mallory Necroses of the Liver. , 2022, The Journal of medical research.